newsfilter
← Latest News
FDA Approved Drugs·

Approval of Unloxcyt, Bla #761297

Approval Date: 11/21/2025; Drug Name: Unloxcyt, Bla #761297; Active Ingredients: COSIBELIMAB-IPDL; Company: Checkpoint Therapeutics Inc; Submission Status: Approval; Application Number: 761297

Company
CHECKPOINT THERAPEUTICS INC
Keywords
CHECKPOINT THERAPEUTICS INC